Omecamtiv mecarbil(CAS: 873697-71-3)

Omecamtiv mecarbil (CAS: 873697-71-3) falls under various regulatory guidelines, including GHS classification for handling and storage, REACH regulations in the EU for registration, evaluation, and authorization, and FDA/EPA requirements for drug approval and safety assessment. It is crucial to adhere to these guidelines to ensure safe and lawful handling.

There are several alternatives to Omecamtiv mecarbil (CAS: 873697-71-3) in synthesis, such as isomers and analogs like omecamtiv mecarbil propionate, which can be used based on specific synthetic requirements. Common alternative reagents include various catalysts and solvents that can facilitate the synthesis process with different efficiency and selectivity.

The market for Omecamtiv mecarbil (CAS: 873697-71-3) is growing due to its potential as a cardiac contractility enhancer for treating heart failure. Research trends are focusing on further clinical trials to validate its efficacy and safety, as well as exploring its mechanisms of action and potential applications in other cardiovascular conditions.

Waste containing Omecamtiv mecarbil (CAS: 873697-71-3) should be handled by collecting it in appropriate containers and disposing of it through professional waste disposal services. Incineration is a common method, and environmental precautions should be taken to prevent contamination. Compliance with local regulations and guidelines is essential for safe disposal.